Health Ministry drafts rules to help Covid-19 patients access new drugs

Seeking to facilitate availability of experimental drugs for severely-ill COVID-19 patients, the Union Health Ministry has issued a draft notification for "compassionate use" of any unapproved drug that is in the phase-III clinical trial globally. Also, if any hospital prescribes a new drug for the same purposes then they may be approved to be manufactured in a limited quantity subject to provisions of the rules.

from India News | Latest News Headlines & Live Updates from India - Times of India https://ift.tt/2A4oqER